Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1951)
Natera, Inc. (NTRA)
Brophy Michael Burkes — CHIEF FINANCIAL OFFICER
Shares
785
Price
$204.13
Total Value
$160.24K
Shares Held After
63,354
% of Holdings
1.2%
Natera, Inc. (NTRA)
Fesko John — PRESIDENT, CHIEF BUS. OFFICER
Shares
707
Price
$204.13
Total Value
$144.32K
Shares Held After
189,199
% of Holdings
0.4%
Natera, Inc. (NTRA)
RABINOWITZ DANIEL — SEC. AND CHIEF LEGAL OFFICER
Shares
1,745
Price
$204.13
Total Value
$356.21K
Shares Held After
233,285
% of Holdings
0.7%
Natera, Inc. (NTRA)
Sheena Jonathan — Director
Shares
127
Price
$204.13
Total Value
$25.92K
Shares Held After
262,325
% of Holdings
0.0%
Enhabit, Inc. (EHAB)
Jolley Julie Diane — EVP of Home Health Operations
Shares
2,793
Price
$13.63
Total Value
$38.07K
Shares Held After
137,130
% of Holdings
2.0%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
2,771
Price
$60.11
Total Value
$166.56K
Shares Held After
4,729
% of Holdings
36.9%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
11,269
Price
$60.11
Total Value
$677.36K
Shares Held After
14,731
% of Holdings
43.3%
Xenon Pharmaceuticals Inc. (XENE)
DiFabio Andrea — Chief Legal Officer
Shares
2,607
Price
$60.11
Total Value
$156.70K
Shares Held After
4,893
% of Holdings
34.8%
Natera, Inc. (NTRA)
Moshkevich Solomon — PRESIDENT, CLINICALDIAGNOSTICS
Shares
915
Price
$204.13
Total Value
$186.78K
Shares Held After
150,882
% of Holdings
0.6%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$15.30
Total Value
$7.65K
Shares Held After
20,406
% of Holdings
2.4%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$15.57
Total Value
$7.78K
Shares Held After
20,906
% of Holdings
2.3%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
300
Price
$15.28
Total Value
$4.58K
Shares Held After
21,406
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
4,968
Price
$59.16
Total Value
$293.91K
Shares Held After
166,818
% of Holdings
2.9%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
2,427
Price
$58.32
Total Value
$141.53K
Shares Held After
171,786
% of Holdings
1.4%
INTUITIVE SURGICAL INC (ISRG)
Curet Myriam — EVP & Chief Medical Officer
Shares
105
Price
$493.95
Total Value
$51.86K
Shares Held After
0
% of Holdings
100.0%
Aquestive Therapeutics, Inc. (AQST)
Barber Daniel — President and CEO
Shares
180,677
Price
$4.17
Total Value
$753.97K
Shares Held After
1,004,753
% of Holdings
15.2%
Aquestive Therapeutics, Inc. (AQST)
Korczynski Sherry — Chief Commercial Officer
Shares
15,741
Price
$4.17
Total Value
$65.69K
Shares Held After
241,117
% of Holdings
6.1%
Aquestive Therapeutics, Inc. (AQST)
BRAENDER LORI J — Chief Legal Officer
Shares
40,102
Price
$4.17
Total Value
$167.35K
Shares Held After
442,879
% of Holdings
8.3%
Aquestive Therapeutics, Inc. (AQST)
TOTH A ERNEST JR — Chief Financial Officer
Shares
58,254
Price
$4.17
Total Value
$243.09K
Shares Held After
376,112
% of Holdings
13.4%
Aquestive Therapeutics, Inc. (AQST)
Jung Cassie — Chief Operating Officer
Shares
45,791
Price
$4.17
Total Value
$191.09K
Shares Held After
274,980
% of Holdings
14.3%
Aquestive Therapeutics, Inc. (AQST)
Boyd Peter E. — Chief People Officer
Shares
29,814
Price
$4.17
Total Value
$124.41K
Shares Held After
338,509
% of Holdings
8.1%
Aquestive Therapeutics, Inc. (AQST)
Cioffi Melina — SVP, Regulatory Affairs
Shares
25,311
Price
$4.17
Total Value
$105.62K
Shares Held After
274,867
% of Holdings
8.4%
Solventum Corp (SOLV)
Wendell Amy McBride — Director
Shares
1,475
Price
$68.03
Total Value
$100.34K
Shares Held After
5,039
% of Holdings
29.3%
Orthofix Medical Inc. (OFIX)
CAPPS VICKIE L — Director
Shares
2,400
Price
$12.45
Total Value
$29.88K
Shares Held After
27,585
% of Holdings
8.7%
Orthofix Medical Inc. (OFIX)
CAPPS VICKIE L — Director
Shares
100
Price
$12.44
Total Value
$1.24K
Shares Held After
25,185
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Caudill Cortney — SVP, CHIEF OPERATING OFFICER
Shares
8,857
Price
$67.64
Total Value
$599.09K
Shares Held After
7,055
% of Holdings
55.7%
Alignment Healthcare, Inc. (ALHC)
KAO JOHN E — Director
Shares
180,000
Price
$18.19
Total Value
$3.27M
Shares Held After
2,472,641
% of Holdings
6.8%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
2,500
Price
$100.11
Total Value
$250.28K
Shares Held After
2,247,500
% of Holdings
0.1%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Horich William Todd — SVP, Commercial Operations
Shares
4,439
Price
$55.00
Total Value
$244.15K
Shares Held After
0
% of Holdings
100.0%
MANNKIND CORP (MNKD)
Castagna Michael — Director
Shares
100,000
Price
$2.59
Total Value
$259.00K
Shares Held After
2,575,911
% of Holdings
3.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,460
Price
$14.68
Total Value
$285.67K
Shares Held After
643,471
% of Holdings
2.9%
Viking Therapeutics, Inc. (VKTX)
Aubuchon Neil William — Chief Commercial Officer
Shares
4,475
Price
$33.50
Total Value
$149.91K
Shares Held After
4,475
% of Holdings
100.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
3,508
Price
$22.67
Total Value
$79.53K
Shares Held After
66,820
% of Holdings
5.0%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
1,000
Price
$6.60
Total Value
$6.60K
Shares Held After
628,813
% of Holdings
0.2%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$10.06
Total Value
$178.23K
Shares Held After
231,584
% of Holdings
7.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
177,690
Price
$17.72
Total Value
$3.15M
Shares Held After
5,285,156
% of Holdings
3.3%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
1,684
Price
$75.58
Total Value
$127.28K
Shares Held After
242,662
% of Holdings
0.7%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
117,604
Price
$75.26
Total Value
$8.85M
Shares Held After
244,346
% of Holdings
32.5%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
7,382
Price
$74.11
Total Value
$547.09K
Shares Held After
361,950
% of Holdings
2.0%
Organogenesis Holdings Inc. (ORGO)
Driscoll Michael Joseph — Director
Shares
10,000
Price
$2.67
Total Value
$26.69K
Shares Held After
225,707
% of Holdings
4.4%
U S PHYSICAL THERAPY INC /NV (USPH)
REEVE GRAHAM D. — COO
Shares
1
Price
$78.52
Total Value
$78.52
Shares Held After
0
% of Holdings
100.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Khan Najat — Director
Shares
28,298
Price
$3.35
Total Value
$94.66K
Shares Held After
2,262,085
% of Holdings
1.2%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
36,766
Price
$19.17
Total Value
$704.66K
Shares Held After
339,392
% of Holdings
9.8%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
5,089
Price
$13.00
Total Value
$66.16K
Shares Held After
132,898
% of Holdings
3.7%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
29,871
Price
$30.02
Total Value
$896.81K
Shares Held After
25,000
% of Holdings
54.4%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
80,000
Price
$35.32
Total Value
$2.83M
Shares Held After
188,954
% of Holdings
29.7%
IONIS PHARMACEUTICALS INC (IONS)
O'NEIL PATRICK R. — EVP CLO & General Counsel
Shares
10,148
Price
$75.25
Total Value
$763.66K
Shares Held After
62,211
% of Holdings
14.0%
Kiniksa Pharmaceuticals International, plc (KNSA)
Ragosa Mark — CHIEF FINANCIAL OFFICER
Shares
18,741
Price
$46.24
Total Value
$866.58K
Shares Held After
12,086
% of Holdings
60.8%
Kiniksa Pharmaceuticals International, plc (KNSA)
Ragosa Mark — CHIEF FINANCIAL OFFICER
Shares
17,981
Price
$45.58
Total Value
$819.57K
Shares Held After
30,827
% of Holdings
36.8%
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
3,116
Price
$13.02
Total Value
$40.58K
Shares Held After
210,482
% of Holdings
1.5%
Showing 801–850 of 1951 transactions (page 17 of 40)